Important #gout study (I'm biased): allopurinol is non-inferior to febuxostat with regards to gout flare when used in a T2T approach, with no differences in AEs, including CV risk. 99% achieved serum urate target over course of trial. Key slides following. #ACR21 https://t.co/tWeGvZ4rKY

OA oral session - abstract 1904 Devin Driscoll (mentor @tuhina_neogi) presenting data from MOST: Evaluation of Neuropathic-like Symptoms and Objective Signs of Neuropathy Post-Knee Replacement #ACR21 https://t.co/APZAJdHH5M

Dr Ami Shah - Scleroderma & Cancer: 🛑 ⬆️ risk of ca around the time of dx in SSc patients with RNA-pol-III (especially first 5 years after dx), anti-Th/To protective? 🛑Her approach for ca screening in newly diagnosed with SSc pts and red flags as below #ACR21 #ACRambassador https://t.co/2VcWn2UInm

IL17 IS Impt in giant cell arthritis. Who would’ve thought that #secukinumab would treat #GCA? More options for pts. Only 52 pts but maybe another Rx for GCA? #ACR21 abst#L19 https://t.co/dwbPmGswQ9

Hair Loss due to Methotrexate from RCTs in RA estimated at 6.9%. It's an understandable source of concern for those taking the medication #ACR21 https://t.co/GymV2RC7jT

@ashira_md blazing through again! Tune in now to hear her talk on #microaggressions and #gaslighting #ACR21 #ACRAmbassador #DEI https://t.co/uqvLxxcs43

🆕 Main findings of #Lupus trials presented at #ACR21 ⬇️ https://t.co/HENxcyLuf5

🗳️Poll of the day for #ACR21 #ACRambassador @ACRheum 🤔What format do you prefer for #ACR22?

Dr. Lane on Ca/Vitamin D in Osteoporosis ⭐️🎯serum vitamin D 25OH ~38 ⭐️Studies since 2008 Auckland Calcium trial DO NOT support incr CV risk with Ca supplementation ⭐️Ca calculator: https://t.co/PLPMfZdIwb ⭐️No sig change in fracture risk with supp #ACR21 #ACRAmbassador https://t.co/KUa52vf4gT

• CALCIUM - Calcium Calculator | International Osteoporosis Foundation

Dr. Fiorentino on cancer risk stratification and screening in myositis. Come chat at noon in the Myositis Community Hub to learn more! #ACR21 #ACRAmbassador https://t.co/I0iQuPAuOl

Thanks Dr David Fiorentino for his talk on CA and myositis! ⬆️risk: - DM - >45-50yo - males - TIF1-gamma Ab (4.7RR of CA) - NXP2 - low CK - dysphagia ⬇️ risk: - synthetase Ab - raynaud - ILD - inflamm arth 🚨TIF1-gamma🚨 - ovarian CA (older, IgG2) #ACR21 #ACRAmbassador

Risk Stratification for CA in IIM Low risk: - no clin RF + at least 1 protective factor - autoAb (Jo1, Mi2, MDA5,SRP,RNP/SSA/SSB) Intmdt risk: - 1-2 clin RF - auto Ab (SAE1, HMGCR) - PM/INMN no Ab Hi riks: - >2 clin RF - h/o CA - autoAb (TIF1g, NXP2) #ACR21 #ACRAmbassador https://t.co/nTBSDcS1v4

Screening for CA in IIM: Low risk: * CXR, age approp CA screen Intmdt risk: * CT c/a/p, tm mrkrs (CA125♀️, PSA♂️), pelvic US, colo <50yo, mammo <50>75) Hi risk (?annually): * whole body PET-CT When? Annual x hi risk? Recalcitrant /Unexpl flare #ACR21 #ACRAmbassador

#ACR21 #pedsrheum I say it counts! I mean, at the end of the day, these are all just pictures of food on the internet, right? #ACRBakeAnythingChallenge https://t.co/bVQuealWWX

• Janet Pope on Twitter: &quot;?Child’S play #ACRBakeAnythingChallenge. Caution m…

Dr. Melissa Munroe - Lupus Classification Risk Immune Index 🔹Pre-/post-classification serum 🔹Avg time➡️classification 4.7y 🔹9 immune mediators altered in pre-clinical dz 🔹Pos score = ⬆️likelihood➡️SLE; Neg = ⬇️ https://t.co/UFEkGieXum 1/2 #ACR21 Abst#1423 @RheumNow #ACRBest

• Ability of Soluble Immune Mediators and SLE-associated Autoantibody Specificiti…